Shelf life expectations Reconstituted with bacteriostatic water and stored properly, GHK-Cu maintains stability for approximately 30 days
Administration and Guidance Tesamorelin is administered via subcutaneous injection, typically once daily
Source Reference: Bliddal H, et al "Once-weekly semaglutide in persons with obesity and knee osteoarthritis" N Engl J Med 2024
There is a theoretical --- though as yet unproven in humans --- risk that long-term or high-dose use could stimulate growth in existing malignant or pre-malignant cells
Potential Side Effects While there are no large randomized controlled studies in the injectable dosage form, some common side effects reported are injection site reactions, nausea, diarrhea, dizziness, fishy body odor, and headache